[ASAP] Construction and Preclinical Evaluation of a < sup > 124/125 < /sup > I ‑Labeled Specific Antibody Targeting PD-L2 in Lung Cancer

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00958

Source: Molecular Pharmaceutics - December 29, 2022 Category: Drugs & Pharmacology Authors: Yuan Yao, Xingguo Hou, Song Liu, Teli Liu, Yanan Ren, Xiaokun Ma, Qian Zhang, Pei Wang, Qian Guo, Xiaopan Ma, Zhi Yang, Hua Zhu, and Nan Li Source Type: research